Open Access Articles- Top Results for 2C-B-BZP


Systematic (IUPAC) name
Clinical data
1094424-37-9 7pxN
ChemSpider 26234933 7pxY
Chemical data
Formula C13H19BrN2O2
315.2085 g/mol
 14pxN (what is this?)  (verify)

4-Bromo-2,5-dimethoxy-1-benzylpiperazine (2C-B-BZP) is a psychoactive drug and research chemical of the piperazine chemical class which has been sold as a "designer drug".[1][2] It produces stimulant effects similar to those of benzylpiperazine (BZP).


2C-B-BZP contains a benzylpiperazine base as well as the ring-substitution pattern of the psychedelic phenethylamine 2C-B, although 2C-B-BZP is not a phenethylamine itself and does not produce psychedelic effects as the binding groups are in the wrong position to activate the 5-HT2A receptor.[citation needed]


2C-B-BZP produces stimulant effects which last 3–6 hours. It is also said by several sources to increase the effects of other compounds when combined[citation needed]. Side effects include headaches and nausea, similar to those of other recreationally-used piperazine derivatives.


2C-B-BZP is unscheduled and uncontrolled in the United States, but possession and sale of 2C-B-BZP could possibly be prosecuted under the Federal Analog Act because of its structural similarities to benzylpiperazine. 2C-B-BZP is illegal to possess, use or sell in Japan where it used to be sold in local smartshops.

See also


  1. ^ Westphal F, Junge T, Girreser U, Stobbe S, Pérez SB (May 2009). "Structure elucidation of a new designer benzylpiperazine: 4-bromo-2,5-dimethoxybenzylpiperazine". Forensic Science International 187 (1-3): 87–96. PMID 19345524. doi:10.1016/j.forsciint.2009.03.003. 
  2. ^ Peters FT, Martinez-Ramirez JA (October 2010). "Analytical toxicology of emerging drugs of abuse". Therapeutic Drug Monitoring 32 (5): 532–9. PMID 20814349. doi:10.1097/FTD.0b013e3181f33411.